Hefei Lifeon Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Hefei Lifeon Pharmaceutical Co Ltd cash flow-to-debt ratio. Hefei Lifeon Pharmaceutical Co Ltd (003020) has a Cash Flow-to-Debt Ratio of 1.02x as of September 2025, meaning its operating cash flow of CN¥667.63 Million could theoretically repay 1% of its total liabilities (CN¥652.24 Million) in one year. Check Hefei Lifeon Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hefei Lifeon Pharmaceutical Co Ltd (2012–2025)
Cash flow-to-debt ratio of Hefei Lifeon Pharmaceutical Co Ltd from 2012 to 2025. Historical debt coverage capacity for Hefei Lifeon Pharmaceutical Co Ltd across 13 annual periods. Check how aggressively does Hefei Lifeon Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Hefei Lifeon Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2012–2025)
Hefei Lifeon Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Hefei Lifeon Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 003020 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.34x | CN¥212.89 Million | CN¥634.19 Million | ▲ +14.4% |
| 2024 | 0.29x | CN¥197.53 Million | CN¥673.38 Million | ▼ -12.1% |
| 2023 | 0.33x | CN¥203.67 Million | CN¥610.18 Million | ▲ +6.7% |
| 2022 | 0.31x | CN¥200.64 Million | CN¥641.53 Million | ▼ -27.0% |
| 2021 | 0.43x | CN¥158.70 Million | CN¥370.53 Million | ▼ -10.1% |
| 2020 | 0.48x | CN¥172.49 Million | CN¥362.03 Million | ▼ -4.3% |
| 2019 | 0.50x | CN¥149.30 Million | CN¥299.82 Million | ▲ +105.0% |
| 2018 | 0.24x | CN¥64.45 Million | CN¥265.31 Million | ▲ +438.8% |
| 2017 | 0.05x | CN¥11.32 Million | CN¥251.14 Million | ▼ -80.9% |
| 2016 | 0.24x | CN¥58.99 Million | CN¥249.71 Million | ▼ -33.2% |
| 2014 | 0.35x | CN¥92.05 Million | CN¥260.11 Million | ▲ +168.2% |
| 2013 | 0.13x | CN¥35.54 Million | CN¥269.34 Million | ▲ +459.3% |
| 2012 | -0.04x | CN¥-7.96 Million | CN¥216.67 Million | — |